clinical trials
Bayer and Novartis to debut new data at ASH 2015
November 30, 2015Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology
Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …
Number of mobile health apps quadruples in two years
September 18, 2015Medical Communications apps, clinical trials, communications, digital, mhealth, technology
The number of mobile health applications available to consumers has reached more than 165,000, as the industry for sensors and …
Counting the true cost of the Cancer Drugs Fund cuts
September 14, 2015Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology
Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …
NHS approves electronic consent technology in clinical trials
August 28, 2015Medical Communications, Research and Development Mytrus, NHS, clinical trials, digital health technology, electronic informed consent
Clinical technology and services company Mytrus has announced that its software platform for electronic informed consent has received approval for …
After the legal case – where next for pharma industry transparency?
August 26, 2015Research and Development clinical trial transparency, clinical trials, health research authority, transparency
Even in an industry as litigious as pharma can sometimes be, the recent legal drama that has played out in …
Clinical Trial Transparency – A Personal View
August 24, 2015Research and Development ABPI, PMCPA, clinical trial transparency, clinical trials, health research authority, transparency
During the time I worked as research, medical and innovation director at the ABPI, between October 2012 and January 2015, …
Mixed Phase 3 results for Sanofi and UCB
July 29, 2015Research and Development LixiLan, Sanofi, UCB, clinical trials, epratuzumab, insulin, insulin glargine, phase III
Two drugs that pharma companies are pinning hopes on for future success have had mixed outcomes in key late-stage clinical …
Judge rules pharma has ‘ethical’ transparency obligation – reaction
July 29, 2015Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency
Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …
Judge backs HRA in transparency legal case
July 28, 2015Research and Development EU Clinical Trial Regulation, Richmond Pharmacology, alltrials, clinical trial regulation, clinical trials, health research authority, sense about science, transparency
A judge has ruled that there are likely to be no legal grounds to block the Health Research Authority’s plans …
EMA in push for more paediatric drug trials
July 24, 2015Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics
The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …
Ruling in transparency case ‘due within days’
July 17, 2015Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency
A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …
It’s time the industry spoke out about legal challenge to clinical trial transparency
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …
Industry awaits outcome of transparency legal challenge
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …
Pharma companies look to Apple’s ResearchKit for R&D
July 13, 2015Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit
Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …
Pharma outsourcing: CROs, CMOs and external collaboration
July 2, 2015Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing
Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …
Latest content
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
